AstraZeneca Manufacturing Error Clouds Vaccine Study Results

AstraZeneca Manufacturing Error Clouds Vaccine Study Results

Outlook

AstraZeneca and Oxford University have acknowledged a manufacturing error that is raising questions about preliminary results of their experimental Covid-19 vaccine.

A statement describing the error on Wednesday came days after the company and the university described the shots as 'highly effective' and made no mention of why some study participants didn't receive as much vaccine in the first of two shots as expected.

In a surprise, the group of volunteers that got a lower dose seemed to be much better protected than the volunteers who got two full doses.

In the low-dose group, AstraZeneca said, the vaccine appeared to be 90 per cent effective.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.

World COVID19 Meter

99274235

Cases

71106610

Recovered

2128677

Deaths
Last updated: GMT
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019